Modulation of recombinant GABA A receptors by neurosteroid dehydroepiandrosterone sulfate

Pharmacology

Volumn 89, Issue 3-4, 2012, Pages 163-171

  Švob Štrac, Dubravka ^a   Jazvinšćak Jembrek, Maja ^a   Erhardt, Julija ^b   Mirković Kos, Kety ^a   Peričić, Danka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Dehydroepiandrosterone sulfate; GABA A receptor; HEK 293 cells; Ligand binding; Long term treatment

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR BETA2; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; BENZODIAZEPINE; FLUNITRAZEPAM; PRASTERONE SULFATE;

ARTICLE; BINDING SITE; CELL MEMBRANE; DRUG RECEPTOR BINDING; DRUG TOLERANCE; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BICYCLO COMPOUNDS, HETEROCYCLIC; CELL MEMBRANE; DEHYDROEPIANDROSTERONE SULFATE; FLUNITRAZEPAM; HEK293 CELLS; HUMANS; RECEPTORS, GABA-A; RECOMBINANT PROTEINS;

EID: 84858331904     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000336058     Document Type: Article

References (35)

1. Wolf OT, Kirschbaum C: Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 1999; 30: 264-288. (Pubitemid 29531488)
2. De Bruin VM, Vieira MC, Rocha MN, Viana GS: Cortisol and dehydroepiandrosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia. Brain Cogn 2002; 50: 316-323. (Pubitemid 36034611)
3. Pérez-Neri I, Montes S, Ojeda-López C, Ramírez- Bermúdez J, Ríos C: Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: Mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1118-1130.
4. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH: Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009; 30: 65-91.
5. Mitchell EA, Herd MB, Gunn BG, Lambert JJ, Belelli D: Neurosteroid modulation of GABA A receptors: Molecular determinants and significance in health and disease. Neurochem Int 2008; 52: 588-595. (Pubitemid 351146675)
6. Majewska MD, Demirgören S, Spivak CE, London ED: The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA A receptor. Brain Res 1990; 526: 143-146. (Pubitemid 20273574)
7. Sousa A, Ticku MK: Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. Pharmacol Exp Ther 1997; 282: 827-833. (Pubitemid 27340184)
8. Shen W, Mennerick S, Zorumski EC, Covey DF, Zorumski CF: Pregnenolone sulfate and dehydroepiandrosterone sulfate inhibit GABA-gated chloride currents in Xenopus oocytes expressing picrotoxin-insensitive GABA(A) receptors. Neuropharmacology 1999; 38: 267-271. (Pubitemid 29073546)
9. Morrow AL, Pace JR, Purdy RH, Paul SM: Characterization of steroid interactions with gamma-Aminobutyric acid receptor-gated chloride ion channels: Evidence for multiple steroid recognition sites. Mol Pharmacol 1990; 37: 263-270. (Pubitemid 20082992)
10. Majewska MD: Neurosteroids: Endogenous bimodal modulators of the GABA A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992; 38: 379-395.
11. Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH: Sulfated and unsulfated steroids modulate -Aminobutyric acid A receptor function through distinct sites. Brain Res 1999; 830: 72-87. (Pubitemid 29251714)
12. Olsen RW, Sieghart W: GABA A receptors: Subtypes provide diversity of function and pharmacology. Neuropharmacology 2009; 56: 141-148.
13. Friedman LK, Gibbs TT, Farb DH: Gammaaminobutyric acid A receptor regulation: Heterologous uncoupling of modulatory site interactions induced by chronic steroid, barbiturate, benzodiazepine, or GABA treatment in culture. Brain Res 1996; 707: 100-109.
14. Biggio G, Dazzi L, Biggio F, Mancuso L, Talani G, Busonero F, Mostallino MC, Sanna E, Follesa P: Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators. Eur Neuropsychopharmacol 2003; 6: 411-423. (Pubitemid 37433962)
15. Cagetti E, Liang J, Spigelman I, Olsen RW: Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABA A receptors. Mol Pharmacol 2003; 1: 53-64. (Pubitemid 36043808)
16. Yu R, Ticku MK: Chronic neurosteroid treatment produces functional heterologous uncoupling at the gamma-Aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol Pharmacol 1995; 47: 603-610.
17. Follesa P, Concas A, Porcu P, Sanna E, Serra M, Mostallino MC, Purdy RH, Biggio G: Role of allopregnanolone in regulation of GABA(A) receptor plasticity during longterm exposure to and withdrawal from progesterone. Brain Res Brain Res Rev 2001; 37: 81-90. (Pubitemid 34020722)
18. Smith SS, Shen H, Gong QH, Zhou X: Neurosteroid regulation of GABA(A) receptors: Focus on the alpha4 and delta subunits. Pharmacol Ther 2007; 116: 58-76. (Pubitemid 47391031)
19. Maguire J, Mody I: Neurosteroid synthesismediated regulation of GABA(A) receptors: Relevance to the ovarian cycle and stress. J Neurosci 2007; 27: 2155-2162. (Pubitemid 46340948)
20. Peričić D, Mirković K, Jazvinšćak M, Besnard F: ( 3 H)t-butylbicycloorthobenzoate binding to recombinant alpha1beta2gamma2s GABA(A) receptor. Eur J Pharmacol 1998; 360: 99-104. (Pubitemid 28529402)
21. Peričić D, Jazvinšćak M, Mirković K: [ 3 H]Flunitrazepam binding to recombinant alpha-1beta2gamma2S GABA A receptors stably expressed in HEK 293 cells. Biomed Pharmacother 2001; 55: 221-228.
22. Fuchs K, Zezula J, Slany A, Sieghart W: Endogenous [ 3 H]flunitrazepam binding in human embryonic kidney cell line 293. Eur J Pharmacol 1995; 289: 87-95.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
24. Besnard F, Even Y, Itier V, Granger P, Partiséti M, Avenet P, Depoortere H, Graham D: Development of stable cell lines expressing different subtypes of GABA A receptors. J Recept Signal Transduct Res 1997; 17: 99-113. (Pubitemid 27057354)
25. McKernan RM, Whiting PJ: Which GABA A -receptor subtypes really occur in the brain? Trends Neurosci 1996; 19: 139-143.
26. Demirgören S, Majewska MD, Spivak CE, London ED: Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABA A receptor. Neuroscience 1991; 45: 127-135.
27. Yamada J, Sugiyama H, Sakuma M, Suga T: Specific binding of dehydroepiandrosterone sulfate to rat liver cytosol: A possible association with peroxisomal enzyme induction. Biochim Biophys Acta 1994; 1224: 139-146. (Pubitemid 24326792)
28. Peričić D, Štrac DS, Jembrek MJ, Rajčan I: Prolonged exposure to gamma-Aminobutyric acid up-regulates stably expressed recombinant alpha1beta2gamma2s GABA A receptors. Eur J Pharmacol 2003; 482: 117-125. (Pubitemid 37505934)
29. Jazvinšćak Jembrek M, Švob Štrac D, Vlainić J, Peričić D: The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res 2008; 61: 234-241.
30. Švob Štrac D, Vlainić J, Jazvinšćak Jembrek M, Peričić D: Differential effects of diazepam treatment and withdrawal on recombinant GABA A receptor expression and functional coupling. Brain Res 2008; 1246: 29-40.
31. Shaw G, Morse S, Ararat M, Graham FL: Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 2002; 16: 869-871.
32. Im WB, Blakeman DP: Correlation between GABAA receptor ligand induced changes in t -butylbicyclophosphoro[ 35 S]-thionate binding and 36 Cl-uptake in rat cerebrocortical membranes. Mol Pharmacol 1991; 39: 394-398.
33. Miller LG, Greenblatt DJ, Roy RB, Gaver A, Lopez F, Shader RI: Chronic benzodiazepine administration. III. Upregulation of gamma-Aminobutyric acid A receptor binding and function associated with chronic benzodiazepine antagonist administration. J Pharmacol Exp Ther 1989; 248: 1096-1101. (Pubitemid 19100761)
34. Kulkarni SK, Ticku MK: Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABAbenzodiazepine receptor ionophore complex in cerebral cortex of rat. Brain Res 1990; 519: 6-11. (Pubitemid 20199664)
35. Yadid G, Sudai E, Maayan R, Gispan I, Weizman A: The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. Neurosci Biobehav Rev 2010; 35: 303-314.